Financial Architects, Inc Agios Pharmaceuticals, Inc. Transaction History
Financial Architects, Inc
- $657 Million
- Q2 2023
A detailed history of Financial Architects, Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Financial Architects, Inc holds 200 shares of AGIO stock, worth $11,502. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$11,502% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$326 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$319 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$279 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$215 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$163 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $3.15B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...